{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:08Z","timestamp":1707523988186},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,31]]},"DOI":"10.7759\/cureus.44502","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:54:47Z","timestamp":1693551287000},"source":"Crossref","is-referenced-by-count":0,"title":["Oral Submucous Fibrosis and Scleroderma: A Review of the Etiopathogenesis, Clinicopathological Correlation, and Management Aspects"],"prefix":"10.7759","author":[{"given":"Sreedevi","family":"J","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubnaz","family":"S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maneesha V","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karuna Thulasi","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/injr.injr_51_18","article-title":"Oral manifestations of autoimmune connective tissue diseases","volume":"13","author":"Pandey A","year":"2018","unstructured":"Pandey A, Pandey M, Pandey VP, Ravindran V. Oral manifestations of autoimmune connective tissue diseases. Indian J Rheumatol. 2018, 13:264-72. 10.4103\/injr.injr_51_18","journal-title":"Indian J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_371_20","article-title":"Oral submucous fibrosis: an overview of a challenging entity","volume":"87","author":"Gupta S","year":"2021","unstructured":"Gupta S, Jawanda MK. Oral submucous fibrosis: an overview of a challenging entity. Indian J Dermatol Venereol Leprol. 2021, 87:768-77. 10.25259\/IJDVL_371_20","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-007-0012-3","article-title":"Autoimmunity in systemic sclerosis: current concepts","volume":"9","author":"Boin F","year":"2007","unstructured":"Boin F, Rosen A. Autoimmunity in systemic sclerosis: current concepts. Curr Rheumatol Rep. 2007, 9:165-72. 10.1007\/s11926-007-0012-3","journal-title":"Curr Rheumatol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1999.tb01997.x","article-title":"Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis","volume":"28","author":"Tsai CC","year":"1999","unstructured":"Tsai CC, Ma RH, Shieh TY. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med. 1999, 28:59-63. 10.1111\/j.1600-0714.1999.tb01997.x","journal-title":"J Oral Pathol Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2005.08.005","article-title":"Oral submucous fibrosis: review on aetiology and pathogenesis","volume":"42","author":"Tilakaratne WM","year":"2006","unstructured":"Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006, 42:561-8. 10.1016\/j.oraloncology.2005.08.005","journal-title":"Oral Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-020-0399-7","article-title":"Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management","volume":"49","author":"Rao NR","year":"2020","unstructured":"Rao NR, Villa A, More CB, Jayasinghe RD, Kerr AR, Johnson NW. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg. 2020, 49:3. 10.1186\/s40463-020-0399-7","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"ref7","article-title":"Oral submucous fibrosis: etiology, pathogenesis, and future research","volume":"72","author":"Rajendran R","year":"1994","unstructured":"Rajendran R. Oral submucous fibrosis: etiology, pathogenesis, and future research. Bull World Health Organ. 1994, 72:985-96.","journal-title":"Bull World Health Organ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.137772","article-title":"Oral submucous fibrosis and its dermatological relation","volume":"5","author":"Ali FM","year":"2014","unstructured":"Ali FM, Patil A, Patil K, Prasant MC. Oral submucous fibrosis and its dermatological relation. Indian Dermatol Online J. 2014, 5:260-5. 10.4103\/2229-5178.137772","journal-title":"Indian Dermatol Online J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/njms.NJMS_32_17","article-title":"Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies","volume":"8","author":"Passi D","year":"2017","unstructured":"Passi D, Bhanot P, Kacker D, Chahal D, Atri M, Panwar Y. Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies. Natl J Maxillofac Surg. 2017, 8:89-94. 10.4103\/njms.NJMS_32_17","journal-title":"Natl J Maxillofac Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2014.08.001","article-title":"Pathophysiology of systemic sclerosis: state of the art in 2014","volume":"43","author":"Dumoitier N","year":"2014","unstructured":"Dumoitier N, Lofek S, Mouthon L. Pathophysiology of systemic sclerosis: state of the art in 2014. Presse Med. 2014, 43:e267-78. 10.1016\/j.lpm.2014.08.001","journal-title":"Presse Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0972-124X.99275","article-title":"Oral and periodontal manifestations associated with systemic sclerosis: a case series and review","volume":"16","author":"Jagadish R","year":"2012","unstructured":"Jagadish R, Mehta DS, Jagadish P. Oral and periodontal manifestations associated with systemic sclerosis: a case series and review. J Indian Soc Periodontol. 2012, 16:271-4. 10.4103\/0972-124X.99275","journal-title":"J Indian Soc Periodontol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen F","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, et al.. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013, 72:1747-55. 10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1954.00710050342011","article-title":"Idiopathic scleroderma of the mouth. Report of three cases","volume":"59","author":"Su I","year":"1954","unstructured":"Su I. Idiopathic scleroderma of the mouth. Report of three cases. AMA Arch Otolaryngol. 1954, 59:330-2. 10.1001\/archotol.1954.00710050342011","journal-title":"AMA Arch Otolaryngol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/000348945706600420","article-title":"LXXXVII submucous fibrosis of the palate and cheek","volume":"66","author":"DeSa JV","year":"1957","unstructured":"DeSa JV. LXXXVII submucous fibrosis of the palate and cheek. Ann Otol Rhinol Laryngol. 1957, 66:1143-59. 10.1177\/000348945706600420","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1972.tb02230.x","article-title":"A new ultrastructural finding in oral submucous fibrosis","volume":"86","author":"Binnie WH","year":"1972","unstructured":"Binnie WH, Cawson RA. A new ultrastructural finding in oral submucous fibrosis. Br J Dermatol. 1972, 86:286-90. 10.1111\/j.1365-2133.1972.tb02230.x","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007%2Fs12663-014-0639-3","article-title":"Oral submucous fibrosis","volume":"16","author":"Morawetz G","year":"19871","unstructured":"Morawetz G, Katsikeris N, Weinberg S, Listrom R. Oral submucous fibrosis. Int J Oral Maxillofac Surg. 19871, 16:609-14. 10.1007%2Fs12663-014-0639-3","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(88)90161-2","article-title":"Analysis of the oral manifestations of systemic sclerosis (scleroderma)","volume":"65","author":"Wood RE","year":"1988","unstructured":"Wood RE, Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Radiol. 1988, 65:172-8. 10.1016\/0030-4220(88)90161-2","journal-title":"Oral Surg Oral Med Oral Radiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen VD","year":"2000","unstructured":"Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000, 43:2437-44. 10.1002\/1529-0131(200011)43:11&lt;2437::AID-ANR10&gt;3.0.CO;2-U","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2020.03.002","article-title":"Cancer and scleroderma","volume":"46","author":"Weeding E","year":"2020","unstructured":"Weeding E, Casciola-Rosen L, Shah AA. Cancer and scleroderma. Rheum Dis Clin North Am. 2020, 46:551-64. 10.1016\/j.rdc.2020.03.002","journal-title":"Rheum Dis Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136%2Fard.62.8.728","article-title":"Risk of cancer in patients with scleroderma: a population based cohort study","volume":"62","author":"Hill CL","year":"2003","unstructured":"Hill CL, Nguyen AM, Roder D, Roberts-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study.  Ann Rheum Dis. 2003, 62:728-31. 10.1136%2Fard.62.8.728","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001662","article-title":"Histopathologic spectrum of morphea","volume":"43","author":"Chiu YE","year":"2021","unstructured":"Chiu YE, Abban CY, Konicke K, Segura A, Sokumbi O. Histopathologic spectrum of morphea. Am J Dermatopathol. 2021, 43:1-8. 10.1097\/DAD.0000000000001662","journal-title":"Am J Dermatopathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103%2F0971-5851.195734","article-title":"Effect of areca nut chewing and maximal mouth opening in school going children in Ahmedabad","volume":"37","author":"Khan AM","year":"2016","unstructured":"Khan AM, Sheth MS, Purohit RR. Effect of areca nut chewing and maximal mouth opening in school going children in Ahmedabad. Indian J Med Paediatr Oncol. 2016, 37:239-341. 10.4103%2F0971-5851.195734","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155%2F2019%2F3497136","article-title":"Oral submucous fibrosis in paediatric patients: a systematic review and protocol for management","volume":"2019","author":"Jain A","year":"2019","unstructured":"Jain A, Saumya T. Oral submucous fibrosis in paediatric patients: a systematic review and protocol for management. Int J Surg Oncol. 2019, 2019:3497136. 10.1155%2F2019%2F3497136","journal-title":"Int J Surg Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9290.33785","article-title":"Oral submucous fibrosis: a clinico-histopathological study in Chennai","volume":"18","author":"Kiran Kumar K","year":"2007","unstructured":"Kiran Kumar K, Saraswathi TR, Ranganathan K, Uma Devi M, Elizabeth J. Oral submucous fibrosis: a clinico-histopathological study in Chennai. Indian J Dent Res. 2007, 18:106-11. 10.4103\/0970-9290.33785","journal-title":"Indian J Dent Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00485.x","article-title":"Oral submucous fibrosis: study of 1000 cases from central India","volume":"36","author":"Hazarey VK","year":"2007","unstructured":"Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN. Oral submucous fibrosis: study of 1000 cases from central India. J Oral Pathol Med. 2007, 36:12-7. 10.1111\/j.1600-0714.2006.00485.x","journal-title":"J Oral Pathol Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20152890","article-title":"Localized scleroderma: clinical spectrum and therapeutic update","volume":"90","author":"Careta MF","year":"2015","unstructured":"Careta MF, Romiti R. Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol. 2015, 90:62-73. 10.1590\/abd1806-4841.20152890","journal-title":"An Bras Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6%3C1359::aid-art228%3E3.0.co;2-s","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett FC","year":"2001","unstructured":"Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001, 44:1359-62. 10.1002\/1529-0131(200106)44:6%3C1359::aid-art228%3E3.0.co;2-s","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.98970","article-title":"Pathogenesis of oral submucous fibrosis","volume":"8","author":"Khan S","year":"2012","unstructured":"Khan S, Chatra L, Prashanth SK, Veena KM, Rao PK. Pathogenesis of oral submucous fibrosis. J Cancer Res Ther. 2012, 8:199-203. 10.4103\/0973-1482.98970","journal-title":"J Cancer Res Ther"},{"key":"ref29","article-title":"Betel chewing and dietary habits of chewers without and with submucous fibrosis and with concomitant oral cancer","volume":"74","author":"Seedat HA","year":"1988","unstructured":"Seedat HA, van Wyk CW. Betel chewing and dietary habits of chewers without and with submucous fibrosis and with concomitant oral cancer. S Afr Med J. 1988, 74:572-5.","journal-title":"S Afr Med J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"Distler JH","year":"2007","unstructured":"Distler JH, J\u00fcngel A, Huber LC, et al.. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum. 2007, 56:311-22. 10.1002\/art.22314","journal-title":"Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12280","article-title":"Histological features of localized scleroderma 'en coup de sabre': a study of 16 cases","volume":"28","author":"Taniguchi T","year":"2014","unstructured":"Taniguchi T, Asano Y, Tamaki Z, et al.. Histological features of localized scleroderma 'en coup de sabre': a study of 16 cases. J Eur Acad Dermatol Venereol. 2014, 28:1805-10. 10.1111\/jdv.12280","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186%2Fs13075-021-02672-y","article-title":"Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality","volume":"23","author":"De Almeida Chaves S","year":"2021","unstructured":"De Almeida Chaves S, Porel T, Mouni\u00e9 M, et al.. Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality. Arthritis Res Ther. 2021, 23:295. 10.1186%2Fs13075-021-02672-y","journal-title":"Arthritis Res Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1054\/bjom.1999.0062","article-title":"Clinical and functional staging of oral submucous fibrosis","volume":"38","author":"Haider SM","year":"2000","unstructured":"Haider SM, Merchant AT, Fikree FF, Rahbar MH. Clinical and functional staging of oral submucous fibrosis. Br J Oral Maxillofac Surg. 2000, 38:12-5. 10.1054\/bjom.1999.0062","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref34","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy EC","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, et al.. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15:202-5.","journal-title":"J Rheumatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200103)44:3%3C735::aid-anr125%3E3.0.co;2-f","article-title":"College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma (letter)","volume":"44","year":"2001","unstructured":"College of Rheumatology preliminary classification criteria for systemic sclerosis. addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma (letter). Arthritis Rheum. 2001, 44:735-6. 10.1002\/1529-0131(200103)44:3%3C735::aid-anr125%3E3.0.co;2-f","journal-title":"Arthritis Rheum"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.15430%2FJCP.2015.20.3.216","article-title":"Association between grading of oral submucous fibrosis with frequency and consumption of areca nut and its derivatives in a wide age group: a multicentric cross sectional study from Karachi, Pakistan","volume":"20","author":"Hosein M","year":"2015","unstructured":"Hosein M, Mohiuddin S, Fatima N. Association between grading of oral submucous fibrosis with frequency and consumption of areca nut and its derivatives in a wide age group: a multicentric cross sectional study from Karachi, Pakistan. J Cancer Prev. 2015, 20:216-22. 10.15430%2FJCP.2015.20.3.216","journal-title":"J Cancer Prev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2015\/1959","article-title":"Recent concepts of etiopathogenesis and management of oral submucous fibrosis: a review of literature","volume":"28","author":"Singh P","year":"2015","unstructured":"Singh P. Recent concepts of etiopathogenesis and management of oral submucous fibrosis: a review of literature. J Evol Med Dent Sci. 2015, 28:13728-42. 10.14260\/jemds\/2015\/1959","journal-title":"J Evol Med Dent Sci"},{"key":"ref38","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano AV","year":"2003","unstructured":"Marzano AV, Menni S, Parodi A, Borghi A, Fuligni A, Fabbri P, Caputo R. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol. 2003, 13:171-6.","journal-title":"Eur J Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.09.79","article-title":"Biomarkers in systemic sclerosis","volume":"4","author":"Castro SV","year":"2010","unstructured":"Castro SV, Jimenez SA. Biomarkers in systemic sclerosis. Biomark Med. 2010, 4:133-47. 10.2217\/bmm.09.79","journal-title":"Biomark Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12583","article-title":"Current protocols in the management of oral submucous fibrosis: an update","volume":"46","author":"Arakeri G","year":"2017","unstructured":"Arakeri G, Rai KK, Boraks G, et al.. Current protocols in the management of oral submucous fibrosis: an update. J Oral Pathol Med. 2017, 46:418-23. 10.1111\/jop.12583","journal-title":"J Oral Pathol Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.19080\/ADOH.2018.07.555716","article-title":"Scleroderma and the oral health implications","volume":"7","author":"Derbi HA","year":"2018","unstructured":"Derbi HA, Borromeo G. Scleroderma and the oral health implications. Advances in Dentistry &amp; Oral Health. 2018, 7:555716. 10.19080\/ADOH.2018.07.555716","journal-title":"Advances in Dentistry & Oral Health"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2016.02.020","article-title":"Oral submucous fibrosis: a review of the current management and possible directions for novel therapies","volume":"122","author":"Warnakulasuriya S","year":"2016","unstructured":"Warnakulasuriya S, Kerr AR. Oral submucous fibrosis: a review of the current management and possible directions for novel therapies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016, 122:232-41. 10.1016\/j.oooo.2016.02.020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4317%2Fjced.51424","article-title":"Comparative study of the efficacy of herbal antioxdants oxitard and aloe vera in the treatment of oral submucous fibrosis","volume":"6","author":"Patil S","year":"2014","unstructured":"Patil S, Halgatti V, Maheshwari S, Santosh BS. Comparative study of the efficacy of herbal antioxdants oxitard and aloe vera in the treatment of oral submucous fibrosis. J Clin Exp Dent. 2014, 6:265. 10.4317%2Fjced.51424","journal-title":"J Clin Exp Dent"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-9-200505030-00029","article-title":"Resolution of severe digital ulceration during a course of Bosentan therapy","volume":"142","author":"Snyder MJ","year":"2005","unstructured":"Snyder MJ, Jacobs MR, Grau RG, Wilkes DS, Knox KS. Resolution of severe digital ulceration during a course of Bosentan therapy. Ann Intern Med. 2005, 142:802-3. 10.7326\/0003-4819-142-9-200505030-00029","journal-title":"Ann Intern Med"},{"key":"ref45","article-title":"Systemic sclerosis\/scleroderma: a treatable multisystem disease","volume":"78","author":"Hinchcliff M","year":"2008","unstructured":"Hinchcliff M, Varga J. Systemic sclerosis\/scleroderma: a treatable multisystem disease. Am Fam Physician. 2008, 78:961-8.","journal-title":"Am Fam Physician"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.4103%2Fidoj.IDOJ_284_19","article-title":"Update on management of morphea (localized scleroderma) in children","volume":"11","author":"George R","year":"2020","unstructured":"George R, George A, Kumar TS. Update on management of morphea (localized scleroderma) in children. Indian Dermatol Online J. 2020, 11:135. 10.4103%2Fidoj.IDOJ_284_19","journal-title":"Indian Dermatol Online J"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.105503","article-title":"PUVA-cream photochemotherapy for the treatment of localized scleroderma","volume":"43","author":"Grundmann-Kollmann M","year":"2000","unstructured":"Grundmann-Kollmann M, Ochsendorf F, Zollner TM, Spieth K, Sachsenberg-Studer E, Kaufmann R, Podda M. PUVA-cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol. 2000, 43:675-8. 10.1067\/mjd.2000.105503","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/143967-oral-submucous-fibrosis-and-scleroderma-a-review-of-the-etiopathogenesis-clinicopathological-correlation-and-management-aspects","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:40Z","timestamp":1707508720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/143967-oral-submucous-fibrosis-and-scleroderma-a-review-of-the-etiopathogenesis-clinicopathological-correlation-and-management-aspects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.44502","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}